L-Ascorbic acid and phosphatidylcholine complex vesicles: formation and elucidation of their biological activities, and their molecular interactions

J Microencapsul. 2023 Jan;40(1):1-14. doi: 10.1080/02652048.2022.2160845. Epub 2022 Dec 28.

Abstract

The aim is to prepare, characterise, and evaluate the biological activities and key molecular interactions of L-ascorbic acid and phosphatidylcholine (PC-AA) complex vesicles. PC-AA complexes were prepared and characterised using DLS, TEM, FTIR, UV-Vis, in-vitro release, bioactivities, and cytotoxicity. The key interactions of the AA with the PC were studied with MD simulations. PC-AA complex provides improved stability towards the degradation of AA in aqueous solutions while also slowing its release profile. The PC-AA complexes with an optimal molar ratio of PC: AA = 2.5:1 was shown to have a hydrodynamic diameter of 368.67 ± 4.65 nm and an EE of 68.16 ± 0.23%. At low concentration, the PC-AA complexes have no toxicity towards human dermal fibroblast cells over 48 h. Importantly, MD suggests that AA only forms the PC-AA complex when in its neutral form which is the desired active form. PC-AA complex could be a potential active to use in medicinal and cosmeceutical applications.

Keywords: L-ascorbic acid; anti-oxidation; hydrogen-bond interaction; molecular dynamic simulations; phosphatidylcholine.

MeSH terms

  • Ascorbic Acid* / pharmacology
  • Humans
  • Lecithins*

Substances

  • Ascorbic Acid
  • Lecithins